Wilkinson Walsh Partner Kieran Gostin Named National Law Journal D.C. Rising Star

WASHINGTON – Wilkinson Walsh Partner Kieran Gostin was named a 2020 National Law Journal D.C. Rising Star. One of 40 honorees, Kieran was recognized for his role on a trial team that won a defense victory for Bayer in a $600 million certified consumer class action lawsuit and his role in the Farar case, where he successfully cross-examined Plaintiffs’ Florida class representative, one of the four witnesses that testified at trial. The award honors attorneys ranging from a variety of practice areas—from appellate to First Amendment to international trade—representing high-profile clients and securing victories. In a Q&A with the National Law Journal, Kieran outlined his biggest accomplishments, most valuable lesson learned, mentorship, and the key to his success. His responses can be found here and below. Describe your biggest win or accomplishment in practice. A defense verdict in a consumer class action about multivitamin advertising. Our client knew it was …

Wilkinson Walsh Partners Rakesh Kilaru and Kieran Gostin Named to Benchmark Litigation “40 & Under Hot List”

WASHINGTON – Wilkinson Walsh Partners Rakesh Kilaru and Kieran Gostin were named to the 2020 Benchmark Litigation “40 & Under Hot List.” Benchmark recognized them as leading and notable up-and-coming litigation partners in the United States. This marks the third consecutive year Rakesh has been recognized by Benchmark. Founding Partner Beth Wilkinson said, “Rakesh and Kieran continue to demonstrate what it means to be stellar attorneys and exemplary role models. I am proud to see their hard work and dedication to achieving the greatest result for their clients in the courtroom being honored and recognized. We are thrilled to have them as part of our team and look forward to their future accomplishments.” Benchmark recognized Rakesh for his involvement in a “wide range of antitrust, sports, product liability, commercial, class action, and appellate litigation,” including high-profile antitrust cases for the national Collegiate Athletic Association (NCAA) and the National Football League …

National Law Journal Recognizes Wilkinson Walsh’s Industry-Leading Products Liability/Mass Tort Trial Practice

WASHINGTON – The National Law Journal selected Wilkinson Walsh as one of its Washington D.C. Litigation Departments of the Year in Products Liability/Mass Torts. NLJ’s selection was based on Wilkinson Walsh’s string of trial victories in high-profile products liability cases.  Most recently, the firm, led by Alex Walsh, Kieran Gostin, and James Rosenthal, won a decisive victory in Bayer v. Farar, a certified consumer class action trial involving $600 million in claimed damages. Previously, the firm reeled off five straight victories in the Xarelto products liability litigation, with Beth Wilkinson, Alex Walsh, Brian Stekloff, Jeremy Barber, Tamarra Matthews Johnson, and Rakesh Kilaru serving in lead roles. NLJ’s profile on the firm highlights commentary from Beth, Alex, and Brian on their strategy and approach to litigation. “We believe that at the heart of every case is a simple compelling narrative, a narrative that shows the jury why our side should prevail,” …

Wilkinson Walsh Celebrates Another Outstanding Year of High Stakes Trials and Accolades for the Next Generation of Trial Lawyers

WASHINGTON –Wilkinson Walsh enters its fifth year having cemented its status as the premier trial litigation boutique in the country. 2019 featured three high-stakes, high-pressure trials, in which different partners served as lead trial counsel and eight partners in total had stand-up roles. The firm continued to receive accolades for its successes in delivering results to its clients while deepening its diverse bench of go-to litigators.

Wilkinson Walsh Announces Three Promotions

WASHINGTON — Wilkinson Walsh today announced three promotions. Kieran Gostin and Ralia Polechronis were elected to the partnership, and Andrew Croner was promoted to counsel. The promotions took effect on June 1. “Kieran, Ralia, and Andrew have each in their own ways played an integral role in many of the firm’s successes, from inside the courtroom to mentoring fellow colleagues,” said founding partner Alex Walsh. “We are truly fortunate to have them in the Wilkinson Walsh family. Their well-deserved promotions are a testament to their value to the firm.” An experienced defense attorney, Kieran has represented government and corporate clients in products liability, antitrust, data breach, copyright, national security, First Amendment, Privacy Act, Administrative Procedure Act, and other complex civil litigation matters. Kieran recently helped lead a trial team that won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit (Farar et al. v. Bayer) …

Litigation Daily: “Killer Crosses: How Wilkinson Walsh Partners Shredded Witnesses in $600M Save for Bayer”

After the Wilkinson Walsh team, led by Sean Eskovitz, Alex Walsh, James Rosenthal, and Kieran Gostin, won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit brought on behalf of One A Day multivitamin consumers, Litigation Daily‘s Jenna Greene wrote about how Eskovitz and Walsh were “so good” at the cross-examinations that “the Wilkinson Walsh team called no defense witnesses. They annihilated the case on crosses alone”: If cross-examination is an art form, then Wilkinson Walsh name partners Alexandra Walsh and Sean Eskovitz (pictured above) are masters. The duo led a trial team defending Bayer AG, which faced a $600 million certified consumer class action over its One A Day multivitamin. The plaintiffs alleged Bayer made false and misleading claims that One A Day supported heart health, immunity and physical energy. How good were the cross-examinations? So good that that the Wilkinson Walsh team called no defense witnesses. They annihilated the case on …

Wilkinson Walsh Secures Trial Win for Bayer in $600 Million One A Day Class Action

WASHINGTON, D.C. — The Wilkinson Walsh team, led by Sean Eskovitz, Alex Walsh, James Rosenthal, and Kieran Gostin, won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit brought on behalf of One A Day multivitamin consumers.  Without calling any witnesses in the defense case, the team relied on devastating cross-examinations of plaintiffs’ expert and fact witnesses to convince the jury to reject plaintiffs’ claims that Bayer had misrepresented the health benefits of One A Day multivitamins.  The jury deliberated for just an hour before returning a complete defense verdict.  The class action suit, filed on behalf of purchasers of One A Day multivitamins in California, New York, and Florida, challenged as false and misleading Bayer’s claims that One A Day multivitamins support heart health, immunity, and physical energy. Plaintiffs originally sought over $4 billion in damages, which Wilkinson Walsh successfully reduced to $600 million …

Wilkinson Walsh Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers

WASHINGTON – Wilkinson Walsh is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of Wilkinson Walsh’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. Wilkinson Walsh won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, Wilkinson Walsh, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, Wilkinson Walsh, led by Kosta Stojilkovic …

Wilkinson Walsh’s Kosta Stojilkovic, Kieran Gostin Named to Law360’s “Rising Stars”

WASHINGTON – Wilkinson Walsh’s Kosta Stojilkovic and Kieran Gostin were named to Law360’s “Rising Stars of 2018,” an honor for “attorneys under 40 whose legal accomplishments transcend their age.” Kosta Stojilkovic was recognized for his trial work, while Kieran Gostin was recognized for his work on products liability matters. “Kosta and Kieran’s well-deserved recognition underscores our firm’s philosophy of empowering younger attorneys to showcase their talent, regardless of age or seniority,” said Wilkinson Walsh Founding Partner Sean Eskovitz. “Kosta and Kieran are litigation superstars, bringing great intellect, judgment, and energy to everything they do, and we are proud that they are leading the way for the next generation of trial lawyers.“ Law360’s Rising Stars for 2018 were selected from over 1,200 submissions and are “based on their career accomplishments in their respective disciplines.” Most recently, Kosta obtained a complete defense verdict in McNair v. NCAA, a high-profile defamation case. At …

Experienced Defense Attorney Kieran Gostin Promoted To Wilkinson Walsh Counsel

WASHINGTON – Wilkinson Walsh today announced that Kieran Gostin has been promoted to Counsel effective January 1, 2018. Since joining Wilkinson Walsh as an associate, Kieran has used his breadth of experience representing government and corporate clients to secure major victories for Wilkinson Walsh’s clients. Kieran most recently helped Bayer win the first state-court bellwether trial over the blood-thinner Xarelto; the trial court entered judgment for Bayer and Janssen notwithstanding a jury verdict in favor of the plaintiff.  He also played a significant role in helping Bayer obtain victories in the first two federal MDL trials relating to Xarelto, with both juries returning complete defense verdicts in under two hours. Kieran’s promotion is a testament to the considerable talent Wilkinson Walsh has amassed in under two years and the ongoing expansion of the firm.  Since its inception, Wilkinson Walsh has grown to nearly 40 lawyers and has quickly established itself …